Ms. Liyuan Liu joined InxMed in March 2023 as Senior Director, CMC (Chemical, Manufacture and Control). She has more than 10 years of work experience in the field of CMC. She had involved multiple projects and 9 products were successfully launched in the market, and 11 patents were granted. Prior to joining Inxmed, she was Vice President of Noventi, responsible for innovative drug development from 2020 to 2023. Prior to that she worked as PM and director in Cinkate Corporation and Jingfeng Pharmaceutical from 2010 to 2020 respectively. Liyuan Liu holds Master degree in Pharmaceutics of the Shanghai Institute of Pharmaceutical Industry.